Parkinson's Disease and α-Synuclein Expression

被引：140

作者：

Devine, Michael J. ^{[1
]}

Gwinn, Katrina ^{[2
]}

Singleton, Andrew ^{[3
]}

Hardy, John ^{[1
]}

机构：

[1] UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England

[2] Baylor Coll Med, Houston, TX 77030 USA

[3] NIA, NIH, Bethesda, MD 20892 USA

来源：

MOVEMENT DISORDERS | 2011年 / 26卷 / 12期

基金：

英国惠康基金; 英国医学研究理事会;

关键词：

Parkinsonism; genetics; alpha-synuclein; MULTIPLE SYSTEM ATROPHY; LEWY BODY; IN-VIVO; SNCA DUPLICATION; GENE DUPLICATION; MOUSE MODEL; NEURODEGENERATIVE DISEASE; DOPAMINERGIC-NEURONS; LOCUS TRIPLICATION; MESSENGER-RNA;

D O I：

10.1002/mds.23948

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Genetic studies of Parkinson's disease over the last decade or more have revolutionized our understanding of this condition. alpha-Synuclein was the first gene to be linked to Parkinson's disease, and is arguably the most important: the protein is the principal constituent of Lewy bodies, and variation at its locus is the major genetic risk factor for sporadic disease. Intriguingly, duplications and triplications of the locus, as well as point mutations, cause familial disease. Therefore, subtle alterations of alpha-synuclein expression can manifest with a dramatic phenotype. We outline the clinical impact of alpha-synuclein locus multiplications, and the implications that this has for Parkinson's disease pathogenesis. Finally, we discuss potential strategies for disease-modifying therapies for this currently incurable disorder. (C) 2011 Movement Disorder Society

引用

页码：2160 / 2168

页数：9

共 50 条

[21] α-Synuclein misfolding and Parkinson's disease
Breydo, Leonid
Wu, Jessica W.
Uversky, Vladimir N.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2012, 1822 (02): : 261 - 285
[22] Neuropathology of α-synuclein in Parkinson's disease
Choong, Chi-Jing
Mochizuki, Hideki
NEUROPATHOLOGY, 2022, 42 (02) : 93 - 103
[23] Aβ and α-synuclein pathologies in Parkinson's disease
Lashley, T.
Holton, J. L.
Gray, E.
Kirkham, K.
Dunn, L.
Wood, N.
Lees, A. J.
Revesz, T.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2007, 33 (02) : 256 - 256
[24] Agrochemicals, α-Synuclein, and Parkinson’s Disease
Blanca A. Silva
Leonid Breydo
Anthony L. Fink
Vladimir N. Uversky
Molecular Neurobiology, 2013, 47 : 598 - 612
[25] Targeting α-synuclein in Parkinson's disease
Kapurniotu, A
CHEMISTRY & BIOLOGY, 2004, 11 (11): : 1476 - 1478
[26] α-synuclein and the pathogenesis of Parkinson's disease
Martin, FL
Williamson, SJM
Paleologou, KE
Allsop, D
El-Agnaf, OMA
PROTEIN AND PEPTIDE LETTERS, 2004, 11 (03): : 229 - 237
[27] α-synuclein gene and Parkinson's disease
Brice, A
SCIENCE, 1998, 279 (5354) : 1116 - 1117
[28] Enteric alpha-synuclein expression is increased in Parkinson's disease but not Alzheimer's disease
Gold, Andrea
Turkalp, Zorbey T.
Munoz, David G.
MOVEMENT DISORDERS, 2013, 28 (02) : 237 - 240
[29] α-synuclein mutation in Parkinson's disease
不详
NEUROSCIENTIST, 1998, 4 (01): : 2 - 3
[30] Agrochemicals, α-Synuclein, and Parkinson's Disease
Silva, Blanca A.
Breydo, Leonid
Fink, Anthony L.
Uversky, Vladimir N.
MOLECULAR NEUROBIOLOGY, 2013, 47 (02) : 598 - 612

← 1 2 3 4 5 →